- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02501369
Investigating the Use of a Positive Parenting Programme to Improve Treatment Adherence in Cystic Fibrosis
A Case Series Examining the Impact of a Positive Parenting Program (Self Directed Teen Triple P) on Treatment Adherence in Families With an Adolescent With Cystic Fibrosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this case series is to begin to explore whether the Teen Triple P program may improve treatment adherence, parent-child relationships, parenting experiences and parent and adolescent wellbeing in families with an adolescent with CF. Research commonly reports that adherence rates to treatment are consistently lower in this age group, with variables such as parent-child conflict, parent stress and the child's increasing independence all being influential factors. Previous research has suggested that family based interventions may facilitate with treatment adherence in this population, but little research has investigated the effectiveness of specific parenting and family based interventions. Triple P is an internationally recognized and extensively researched parenting intervention that has been found to support families from an array of clinical and non-clinical samples, and has been shown to reduce family conflict in other chronic health conditions. No research to date has examined the use Triple P interventions in cystic fibrosis and so hence the current research.
A within subjects clinical case series using an A-B multiple baseline design will be used. This type of design exposes participating parents to a multiple baseline period (phase A) followed by an intervention phase (phase B). This controls for potential confounds, which increases confidence that change is attributable to the use of the parenting intervention. The baseline phase will vary in length from 2 to 6 weeks. During this phase, parents will complete the treatment adherence questionnaire and parenting scale (outlined in the outcome measures section) at weekly intervals which will take 10 minutes each week (the first and last baseline session will involve completing all questionnaires stated in the primary and secondary outcome measures section). The baseline phase will be followed by the 10 week intervention phase. Here parents will commence the self-directed Teen Triple P programme. Parents will be posted a copy of the Teen Triple P workbook. They will complete a 1 hour module of Triple P each week and will also continue to complete the treatment adherence questionnaire and parenting scale each week. At week 5 and 10 of the intervention, the full set of outcome questionnaires will be administered, as well as a satisfaction survey to determine how parents are finding the Triple P intervention. Once the 10 week Triple P intervention has been completed a period of 4 weeks will elapse before the researcher will contact the parents again in order for them to complete a set of 1 month follow up questionnaires, as well as answering some questions about their experiences of taking part in the Triple P intervention.
Children themselves will not be required to participate in any study related activity as this is primarily a parenting intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parents of adolescents (aged 11 to 16) with Cystic Fibrosis.
- Self reported difficulties with their child's treatment adherence.
Exclusion Criteria:
- Families already receiving psychological support from specialist Cystic Fibrosis clinical psychologists
- Parents requiring reading assistance who do not have anyone to help them
- Families where the parent/ child is currently being treated for a mental health difficulty
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Self-directed Teen Triple P
Self-directed Teen Triple P is a behaviourally based parenting intervention that parents follow at home using a workbook. It is based upon social learning theory principles and is used to help parents build upon their existing skills and information to practice positive parenting. Key skills promoted include: Increasing positive parent-teenager interactions, increase desirable behaviour, teach new behaviours and skills, and manage problem behaviour. As this is a case series design participants will act as their own controls and so there are no other arms to the study. |
Manualised parenting programme that parents will complete at home.
This involves reading weekly modules of the manual and completing small exercises to practice the skills taught.
These include strategies to help build positive relationships between parent and child, helping parents to effectively manage challenging childhood behaviours, and providing parents with the skills to support their child's independence and independent management of their cystic fibrosis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Treatment Adherence from baseline as measured by Treatment Adherence Questionnaire - Revised (Quittner et al., 2008)
Time Frame: baseline, intervention weeks 1, 2,3,4,5,6,7,8,9,10, and 1 month follow up
|
consists of 12 items across four subscales corresponding to different domains of CF treatment regime.
It asks about adherence to various elements of treatment in the last week.
Answers are measured across a 6 point Likert scale ranging from "not at all" to "3 or more times a day".
Internal consistency (α=.82-.84) and test-retest reliability (r's=.42-.57)
have been examined.
This measure takes a maximum of 5 minutes to complete.
|
baseline, intervention weeks 1, 2,3,4,5,6,7,8,9,10, and 1 month follow up
|
|
Change in parenting skill and competence from baseline as measured by The Parenting Scale (PS; Arnold et al., 1993)
Time Frame: baseline, intervention weeks 1, 2,3,4,5,6,7,8,9,10, and 1 month follow up
|
30 item questionnaire measuring parent discipline styles.
It has adequate internal consistency, good test-retest reliability and reliably distinguishes between clinical and non-clinical samples.
This measure takes approximately 10 minutes to complete.
|
baseline, intervention weeks 1, 2,3,4,5,6,7,8,9,10, and 1 month follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in parent stress from baseline as measured by Pediatric Inventory for Parents: PIP (Streisand et al., 2001)
Time Frame: baseline,weeks 5 and 10 of intervention, and 1 month follow-up
|
This has 42 items that ask parents to describe the frequency and intensity with which they experience stress related to caring for their child's illness across four domains: (a) communication (b) emotional functioning (c) child's medical care and (d) role functioning.
Parents indicate on a scale from 1 (never) to 5 (very often) how often an event had occurred in the past 7 days and how difficult each event was.
Internal consistency for the PIP has been shown to be good for both scales, frequency: α = .94,
difficulty: α = .96
|
baseline,weeks 5 and 10 of intervention, and 1 month follow-up
|
|
Change in parent's sense of competence from baseline as measured by Parent Sense of Competency Scale (PSOC; Gibaud-Wallston & Wandersman, 1978)
Time Frame: baseline,weeks 5 and 10 of intervention, and 1 month follow-up
|
A 17 item measure assessing parental competence on two dimensions: satisfaction with the parenting role and feelings of efficacy as a parent.
This also has good internal consistency and test-retest reliability.
This measure takes approximately 5 minutes to complete
|
baseline,weeks 5 and 10 of intervention, and 1 month follow-up
|
|
Change in child's emotional wellbeing and behavioural difficulties from baseline as measured by Strengths and Difficulties Questionnaire (SDQ: Goodman, 1997)
Time Frame: baseline,weeks 5 and 10 of intervention, and 1 month follow-up
|
a brief behavioural screening questionnaire about 3-16 year olds.
Parents are asked 25 questions about their child, which are divided between 5 subscales: emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship problems and prosocial behaviour.
Parents rate each item as "not true", "somewhat true", and "always true" of their child.
This measure has very good psychometric properties and is used as a routine child wellbeing outcome measure in many child mental health teams in the UK.
|
baseline,weeks 5 and 10 of intervention, and 1 month follow-up
|
|
Change in parent emotional wellbeing from baseline as measured by The Depression, Anxiety and Stress Scale - 21 item version (DASS-21)
Time Frame: baseline,weeks 5 and 10 of intervention, and 1 month follow-up
|
a 21 item self-report Questionnaire designed to measure the severity of a range of symptoms common to both Depression and Anxiety.
Parents rate their responses to each item on a 4 point Likert scale from "never" to "almost always".
The reliability and validity of this measure is very good, with internal consistency and validity being scored in the acceptable to excellent ranges
|
baseline,weeks 5 and 10 of intervention, and 1 month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parent satisfaction with the intervention at mid and end intervention points as measured by Client Satisfaction Questionnaire
Time Frame: weeks 5 and 10 of intervention
|
is designed to collect information to evaluate the different interventions and help to improve the Triple P programme.
Administered only at post-intervention the questionnaire addresses the quality of the intervention, the extent to which it met the participant's needs, the effect it had on their parenting skills and child's behaviour problems.
All items are measured on a 7 point Likert scale.
|
weeks 5 and 10 of intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rachel Calam, PhD, University of Manchester
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15059
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystic Fibrosis
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
Dartmouth-Hitchcock Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingCystic Fibrosis (CF) | Cystic Fibrosis Gastrointestinal DiseaseUnited States
-
Reistone Biopharma Company LimitedRecruiting
-
AstraZenecaRecruitingNon-cystic Fibrosis BronchiectasisChina
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
-
University of Colorado, DenverCystic Fibrosis FoundationTerminatedCystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in ChildrenUnited States
-
Royal College of Surgeons, IrelandThe Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaboratorsActive, not recruitingCystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver DiseaseUnited Kingdom, Ireland
-
Herlev and Gentofte HospitalCopenhagen University Hospital, DenmarkActive, not recruitingMyocardial Infarction | Heart Diseases | Heart Failure | Stroke | Cystic Fibrosis | Heart Failure, Diastolic | Heart Failure, Systolic | Left Ventricular Dysfunction | Cystic Fibrosis-related Diabetes | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas | Cystic Fibrosis, Pulmonary | Cystic...Denmark
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
-
The Hospital for Sick ChildrenCanadian Cystic Fibrosis FoundationActive, not recruitingCystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in ChildrenCanada
Clinical Trials on Self-directed Teen Triple P
-
University of ManchesterRoyal Children's HospitalCompleted
-
Texas Tech UniversityAmerican Psychological FoundationActive, not recruitingPositive Parenting SkillsUnited States
-
University of OxfordOxford University Hospitals NHS TrustUnknown
-
McMaster UniversityUniversity of Manitoba; Institute for Clinical Evaluative Sciences; University... and other collaboratorsCompleted
-
St. Louis UniversityCompleted
-
Universidad de los Andes, ChileMunicipalidad de Lo Barnechea, ChileRecruiting
-
Ruhr University of BochumUnknownMental Disorders During Pregnancy
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH); Northwestern University; University...CompletedDepression, PostpartumUnited States
-
Temple University Collaborative on Community InclusionCompletedSchizophrenia | Bipolar Disorder | Major Depression
-
Friendi.fi CorporationNational Institute of Mental Health (NIMH); Indiana University; University of... and other collaboratorsRecruiting